Stockreport

Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF - Priced oversubscribed $40 million underwritten registered direct offering with participation from new and existing healthcare dedicated investors - - Issuance of ne [Read more]